findmyKOL

Norman Zabriskie, MD

Basic profile

University of Utah

ORCIDNone on fileNPI
RegionSalt Lake City, UT · WestSpecialtyOphthalmologyFocusOphthalmology
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2011Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Norman Zabriskie is an Ophthalmology physician affiliated with University of Utah. OpenAlex indexes 23 publications with 3,166 citations (h-index 17).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
23publications

Distinct works indexed by OpenAlex.

3,166citations

Total citations across indexed works.

17h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

65 S Mario Capecchi Dr
Salt Lake City, UT 841320005

Telephone

015-812-3528

Provider last certified this registry record 11 Apr 2023.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    83%
    Prostaglandin Analog32.4%
    Latanoprost82%Lumigan13%Travoprost5%
    Part D205 patients
    Carbonic Anhydrase Inhibitor27%
    Dorzolamide-Timolol63%Dorzolamide Hcl26%Brinzolamide7%Simbrinza4%
    Part D<11 patients

    + 4 more classes in this area

  • Cardiovascular

    12.4%
    Beta blocker12.4%
    Timolol Maleate100%
    Part D108 patients
  • Anti-infectives

    3.6%
    Fluoroquinolone Antibacterial1.6%
    Moxifloxacin100%
    Part D34 patients
    Macrolide1.3%
    Erythromycin100%
    Part D20 patients

    + 1 more class in this area

Where care is delivered (Part B)98.2% facility · 1.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”